US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Radiopharm Theranostics Ltd (RADX)
Radiopharm Theranostics Ltd (RADX) ニュース

RADX

Radiopharm Theranostics (RADX)

Radiopharm Theranostics Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RADX

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/03/17	21 : 56	GlobeNewswire Inc.	New RAD202 Data Confirms Positive Tumor Uptake and Favorable Biodistribution	NASDAQ:RADX	Radiopharm Theranostics Ltd
2025/03/17	21 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:RADX	Radiopharm Theranostics Ltd
2025/03/07	20 : 20	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:RADX	Radiopharm Theranostics Ltd
2025/03/01	06 : 45	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:RADX	Radiopharm Theranostics Ltd
2025/02/10	22 : 00	GlobeNewswire Inc.	New Clinical Trial Data Highlights RAD 101 (18F-Pivalate) Successfully Detects Brain Metastases	NASDAQ:RADX	Radiopharm Theranostics Ltd
2025/01/30	22 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:RADX	Radiopharm Theranostics Ltd
2025/01/10	22 : 00	GlobeNewswire Inc.	Lantheus Increases to 12.16% shareholding in Radiopharm with US$5m (A$8m) Placement	NASDAQ:RADX	Radiopharm Theranostics Ltd
2025/01/10	21 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:RADX	Radiopharm Theranostics Ltd
2024/12/30	22 : 00	GlobeNewswire Inc.	Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia	NASDAQ:RADX	Radiopharm Theranostics Ltd
2024/12/30	20 : 31	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:RADX	Radiopharm Theranostics Ltd
2024/12/20	22 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:RADX	Radiopharm Theranostics Ltd
2024/12/20	22 : 00	GlobeNewswire Inc.	RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial	NASDAQ:RADX	Radiopharm Theranostics Ltd
2024/12/19	22 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:RADX	Radiopharm Theranostics Ltd
2024/12/18	22 : 28	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:RADX	Radiopharm Theranostics Ltd
2024/12/16	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:RADX	Radiopharm Theranostics Ltd
2024/12/13	23 : 45	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:RADX	Radiopharm Theranostics Ltd
2024/12/10	20 : 23	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:RADX	Radiopharm Theranostics Ltd
2024/12/06	06 : 02	Edgar (US Regulatory)	Form F-1 - Registration statement for certain foreign private issuers	NASDAQ:RADX	Radiopharm Theranostics Ltd
2024/11/27	22 : 00	GlobeNewswire Inc.	Radiopharm Achieves Nasdaq Listing of American Depositary Shares	NASDAQ:RADX	Radiopharm Theranostics Ltd

Showing the most relevant articles for your search:NASDAQ:RADX

1

Portugal Tf 1,65% Lg32 Eur

Ggb Fb30 Sc Eur

WisdomTree International...

Cdp Tf 1,98% Mz28 Eur

Brera Tv Mg72 Abs Amort ...

Hungary Fx 5.375% Sep33 ...

Bnp Mc Ap29 Eur

Bei Fx 7% Sep25 Pln

World Bank Green Bond Tf...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約